Turn Therapeutics TTRX
NASDAQ TTRX
$9.80 -0.27 (-2.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

Turn Therapeutics (TTRX) Amortizatization of Intangibles (2025 - 2026)

Turn Therapeutics (TTRX) posted quarterly Amortizatization of Intangibles of $14451.0 for Q1 2026, up 16.33% year-over-year from $12422.0 in Q1 2025, and up 16.33% quarter-over-quarter from $12422.0 in Q1 2025.

Analysis

Turn Therapeutics (TTRX) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Turn Therapeutics' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $14451.0 for Q1 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Turn Therapeutics 302.05 Mn 302.05 Mn - 14,531.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,531.00
Mar 31, 2026 14,451.00
Sep 30, 2025 13,679.00
Jun 30, 2025 12,490.00
Mar 31, 2025 12,422.00